View this email in your browser
News Roundup
February 9, 2021
Updates from CLIC  
Tackling the Digital Divide to Improve Telehealth. Friday, March 26, 2021. 11:00am-3:00pm. Un-Meeting hosted by the Clinical and Translational Science Collaboration of Cleveland. Registration is coming soon!

An Un-Meeting on Tackling the Digital Divide to Improve Telehealth

This "Un-Meeting" will focus on tackling the digital divide by developing a better understanding of barriers to access, utilization and disease monitoring in telehealth visits.

Telehealth was rapidly adopted during the COVID-19 pandemic, demonstrating its importance in clinical care. Telehealth represents a new healthcare delivery model that can now be used by researchers to study health outcomes at the population level. Bringing participants together for this meeting will inform the consortium and those involved with telehealth about the relevance and criticalness of connecting team members while providing the best care possible.

Registration coming soon!

Friday, March 26, 11:00 a.m. - 3:00 p.m. ET

Graphic of graphs and people working on a laptop in the background

Common Metrics Multi-Year Report: 2015–2019

The fourth CM Multi-Year Report: 2015-2019 is on its way! This report includes five years of metric data values for the Careers in Clinical & Translational Research Metric and for the first time it will also include the Informatics Metric data. CTSA Program institutions will receive their reports via their designated report page on the CLIC website no later than February 26, 2021.
Two webinars have been scheduled for March 18 and March 29 to present CLIC’s data methodology, visualizations, interpretation, and overall report content. Hubs will have an opportunity to ask questions. We encourage all hubs to register for one of these webinars.

Twitter Highlight
View this post on Twitter. Follow and engage with us here
News from around the CTSA Program Consortium
Amir Zeki, associate professor in the Division of Pulmonary and Critical Care Medicine at UC Davis and co-founder of InVixa Inc.

UC Davis Licenses Novel COVID-19 Lung Treatment Using Inhaled Statins to InVixa, Inc

The University of California, Davis and InVixa Inc., a biopharmaceutical startup, have executed a licensing agreement for a novel method using inhaled statins to treat the severe respiratory disease known as COVID-19. The license, negotiated by the InnovationAccess team within the UC Davis Office of Research, provides exclusive access for InVixa to commercialize the technology developed at the university for COVID-19.

While statins are one of the most prescribed drugs on the market, typically used to treat cardiovascular diseases such as coronary artery disease and stroke by lowering cholesterol levels in the blood, some studies have demonstrated a potential link to improved outcomes in some lung diseases due to statins’ immune-modulatory properties.

Tiffany Danielle Chisholm Pineda

Storytelling event amplifies the unique experiences of Black research professionals throughout UF

It’s a truth that continually motivates those who work to create justice for all members of society: widespread, systematic change begins at the individual level by engaging and influencing hearts and minds, one person at a time.

The UF Clinical and Translational Science Institute’s Diversity and Cultural Competence Council aims to create a just, equitable and comfortable environment for UF research professionals who may be discriminated against by their peers, including but not limited to people of color, the LGBTQIA+ community and the differently abled. In an effort to encourage the individual work needed to create this paradigm shift, the council orchestrated a storytelling event that premiered on YouTube last Thursday and is available to view online.

Tiffany Danielle Chisholm Pineda, research navigator for the Clinical and Translational Science Institute, or CTSI, and chair of the council, said storytelling is a vehicle for change that appeals to listeners by sharing relatable yet unique experiences.

Tell Bennett
Headshots of Tell Bennett and Richard Moffitt
Richard Moffitt

N3C Cohort Paper Available as Preprint

Researchers have been anxious to learn what variables describe the COVID-19 patient cohort. Using the harmonized data in the N3C Data Enclave from 39 institutions’ electronic health records around the country, collaborators were able to distill this information in the manuscript titled "The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction" and is now available for publication.

Lead authors Tell Bennett, M.D., of University of Colorado Anschutz Medical Campus and Richard Moffitt, Ph.D., of Stony Brook Medicine spearheaded this paper along with many other members of the N3C consortium. The paper is out for submission for journal publication and is currently available in medRxiv as a preprint. This consortium paper will serve as the cornerstone for many N3C publications to come.
For more information, please visit the National COVID Cohort Collaborative (N3C) website at

Indiana CTSI annual report earns Gold MarCom Award

Indiana CTSI was recently honored with a Gold MarCom Award for its 2020 Annual Report. The MarCom Awards is an international competition for marketing and communications materials and programs. The program is administered by the Association of Marketing and Communication Professionals.

ICYMI: News from the Science & Research World

Black-legged ticks feeding on a five-lined skink. Credit: Graham Hickling.

Lizards may be protecting people from Lyme disease in the southeastern United States

Lyme disease is one of the most devastating tick-borne infections in the United States, affecting more than 300,000 people each year. It’s also one of the most mysterious: The creature that spreads it—the black-legged tick—lives throughout the country. Yet the northeastern United States is home to far more cases than anywhere else. Now, researchers have identified an unexpected reason: lizards.

CTSA Program Coordinating Centers' News

Is COVID-19 Plasma Helping Prevent Serious Illness in Others?

Could plasma from people who recovered from COVID-19 be used to prevent serious illness in others? Dr. Shmuel Shoham runs the leading COVID-19 clinical trial out of Johns Hopkins University and joins Dr. Ian Smith to discuss how the process works.

Can crowd-sourcing help advance open science?

Crowd-sourced Challenge initiatives in biomedical research provide a mechanism for transparent and rigorous performance assessment. The core idea of these studies is simple. A group of researchers, typically called the “organizers,” identify a key problem that has a diversity of potential solutions. These solutions are typically computational, meaning that each is a different algorithm or method.

If you have a story, opportunity, project or event that you'd like included in the News Roundup, please contact CLIC Communications: or visit the CLIC Library to learn how to post  content to the CLIC website

The University of Rochester Center for Leading Innovation and Collaboration (CLIC) is the coordinating center for the Clinical and Translational Science Awards (CTSA) Program, funded by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), Grant U24TR002260.
Copyright © 2020 University of Rochester - CLIC, All rights reserved.
You are receiving this email because you are subscribed to an existing listserv. You may opt out at any time.

Our mailing address is:
University of Rochester - CLIC
265 Crittenden Blvd
Rochester, NY 14642-0001
Add us to your address book

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
University of Rochester - CLIC · 265 Crittenden Blvd · CU 420708 · Rochester, NY 14642-420708 · USA